Are multiple sclerosis therapies safe in severe acute respiratory syndrome coronavirus 2 times?
Indian J Pharmacol
; 52(5): 441-442, 2020.
Article
in En
| MEDLINE
| ID: mdl-33283779
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pandemics
/
COVID-19
/
Immunosuppressive Agents
/
Multiple Sclerosis
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Indian J Pharmacol
Year:
2020
Document type:
Article
Affiliation country:
Italy